Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?

Investigation into predictors for treatment outcome is essential to improve the clinical efficacy of therapeutic multipotent mesenchymal stromal cells (MSCs). We therefore studied the possible harmful impact of immunogenic ABO blood groups antigens – genetically governed antigenic determinants – at...

Descripción completa

Detalles Bibliográficos
Autores principales: Moll, Guido, Hult, Annika, von Bahr, Lena, Alm, Jessica J., Heldring, Nina, Hamad, Osama A., Stenbeck-Funke, Lillemor, Larsson, Stella, Teramura, Yuji, Roelofs, Helene, Nilsson, Bo, Fibbe, Willem E., Olsson, Martin L., Le Blanc, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890285/
https://www.ncbi.nlm.nih.gov/pubmed/24454787
http://dx.doi.org/10.1371/journal.pone.0085040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890285/
https://www.ncbi.nlm.nih.gov/pubmed/24454787
http://dx.doi.org/10.1371/journal.pone.0085040

Ejemplares similares